NIL Statement of deviation(s) or variation(s) for the quarter ended 31.12.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shree Hari Chemicals Export Ltd has filed a NIL statement of deviation or variation for the quarter ended December 31, 2025, confirming that the proceeds from its Preferential Issue have been used strictly in line with the originally disclosed objects. The total funds raised across four tranches (November 15, 2024; March 15, 2025; July 10, 2025; and July 11, 2025) amount to Rs. 14,74,59,820 (around Rs. 14.75 crore). The filing, submitted under SEBI's Listing Regulation 32, also notes that no monitoring agency was applicable and the Audit Committee had no comments. Overall, this is a routine compliance confirmation indicating no misuse or reallocation of the funds raised.
For shareholders, this is a routine positive compliance disclosure — it reassures that the Rs. 14.75 crore raised via preferential issues is being used as planned, with no deviation. No direct stock price catalyst is expected, but it removes any governance concern related to fund misuse.